Skip to main content

Alumis Inc.

ALMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001847367

In the last 90 days, Alumis Inc. insiders filed 1 open-market purchase and 8 sales; 198 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.

Superinvestors holding ALMS, Q2 2026

See all superinvestors

No superinvestor reported holding ALMS in Q2 2026.